AIL
ALNY icon

AGF Investments LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

AGF Investments LLC’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,434
Closed -$887K – 387
2022
Q1 		$887K Buy
+5,434
New +$828K 0.07% 127
2021
Q2 		– Sell
-4,132
Closed -$583K – 429
2021
Q1 		$583K Sell
4,132
-1,979
-32% -$298K 0.07% 202
2020
Q4 		$794K Sell
6,111
-4,226
-41% -$564K 0.09% 147
2020
Q3 		$1.5M Buy
10,337
+1,027
+11% +$146K 0.17% 56
2020
Q2 		$1.38M Buy
9,310
+9,246
+14,447% +$1.25M 0.14% 112
2020
Q1 		$7K Buy
+64
New +$7.39K ﹤0.01% 494
2018
Q2 		– Sell
-262
Closed -$24K – 826
2018
Q1 		$24K Buy
262
+106
+68% +$13.7K ﹤0.01% 443
2017
Q4 		$20K Buy
156
+70
+81% +$8.8K ﹤0.01% 424
2017
Q3 		$11K Buy
+86
New +$7.34K ﹤0.01% 448

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AGF Investments LLC's ALNY Position: Q2 2022 in Review

AGF Investments LLC sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2022, closing a stake of 5,434 shares — an estimated $887K sold.

AGF Investments LLC first reported a position in ALNY in Q3 2017 and held it in 9 quarters. The position peaked at $1.5M in Q3 2020. 422 funds tracked by Wall St. Rank hold ALNY as of Q2 2022.

  • AGF Investments LLC reported no remaining Alnylam Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • AGF Investments LLC sold 5,434 Alnylam Pharmaceuticals shares in Q2 2022, an estimated $887K.
  • AGF Investments LLC first reported a position in Alnylam Pharmaceuticals in Q3 2017 and held it in 9 quarters.
  • AGF Investments LLC's Alnylam Pharmaceuticals position peaked at $1.5M in Q3 2020.
  • 422 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2022.

Based on AGF Investments LLC's 13F filing for Q2 2022, filed 12 Aug 2022.